{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["14"],"submitter":["Zhai J"],"pubmed_abstract":["Primary renal epithelioid angiosarcoma (EAS) is extremely rare and carries a poor prognosis. Herein, we present a case of renal EAS in an 81-year-old male patient who complained of hematuria for 1 year. A computerized tomography (CT) scan revealed an occupying lesion at the upper pole of the left kidney, with scattered calcifications, along with retroperitoneal lymph node metastasis and possible lung metastasis. A laparoscopic palliative nephrectomy was performed, and postoperative pathology confirmed a malignant tumor with necrosis in the left kidney. Immunohistochemistry (IHC) revealed positive expression for CD31, CD10, and vimentin, consistent with the diagnosis of EAS. Although EAS is a rare, aggressive, and often misdiagnosed condition, IHC can help confirm its diagnosis, and in our "],"journal":["Frontiers in oncology"],"pagination":["1461165"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11646802"],"repository":["biostudies-literature"],"pubmed_title":["Case report: A rare case of renal epithelioid angiosarcoma."],"pmcid":["PMC11646802"],"pubmed_authors":["Tang K","Che B","Shen J","Li T","Zhang Y","Cen K","Zhai J","Tang D"],"additional_accession":[]},"is_claimable":false,"name":"Case report: A rare case of renal epithelioid angiosarcoma.","description":"Primary renal epithelioid angiosarcoma (EAS) is extremely rare and carries a poor prognosis. Herein, we present a case of renal EAS in an 81-year-old male patient who complained of hematuria for 1 year. A computerized tomography (CT) scan revealed an occupying lesion at the upper pole of the left kidney, with scattered calcifications, along with retroperitoneal lymph node metastasis and possible lung metastasis. A laparoscopic palliative nephrectomy was performed, and postoperative pathology confirmed a malignant tumor with necrosis in the left kidney. Immunohistochemistry (IHC) revealed positive expression for CD31, CD10, and vimentin, consistent with the diagnosis of EAS. Although EAS is a rare, aggressive, and often misdiagnosed condition, IHC can help confirm its diagnosis, and in our ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024","modification":"2025-04-18T12:56:00.037Z","creation":"2025-04-06T22:23:03.957Z"},"accession":"S-EPMC11646802","cross_references":{"pubmed":["39687884"],"doi":["10.3389/fonc.2024.1461165"]}}